Cancer, breast cancer and breast cancer symptom can be prevented and may be cured with out any magic bullet according to two time Nobel Prize winner DR. OTTO WARBURG.

In 1931, DR. OTTO WARBURG who won his first Nobel Prize for his work on the cause of Cancer, claims that cancer begins to thrive in your body due to a lack of oxygen respiration in cells. DR. WARBURG'S research proves that cancer is no longer mystical, but infact occurs when any cell is denied 60% of it's oxygen requirement needed to produce energy.

According to DR. WARBURG, cancer unlike other diseases, may have many other secondary causes, but there is just the one prime cause, which relates to the oxygen requirement for cellular respiration.

He continues to explain that all normal body cells meet their energy needs by aerobic cellular respiration, whereas cancerous cells can only meet their energy needs in great parts through the process of fermentation, or anaerobically.

Cellular respiration, being a normal every day process of your healthy working body is required by every cell in order to produce energy for your body to function effectively, or you may experience breast cancer or breast cancer symptom.

As the blood picks up oxygen from the lungs, this oxygen must be efficiently circulated throughout the body to distribute nutrients and to produce energy in the cells. Any obstruction due to the clumping of plaque, from free radicals oxidation of LDL cholesterol, toxins and carcinogens, or from unhealthy blood platelets activities, inhibits the needed oxygen requirement of 60% for optimum cellular respiration according to DR. WARBURG, thus creating the formation of malignant cells.

The diagnosis of breast cancer is overwhelming. After the initial phase of diagnosis comes the discussion of your breast cancer treatment type. This decision should involve more than just your physician.

Choosing the most appropriate breast cancer treatment type is a decision that ideally involves the patient, family, and healthcare team.

Ultimately, you and your physician must decide which breast cancer treatment type is right for you. While you need the input from friends and family the decision should be yours.

You should feel confident about the decision you make. Becoming educated to what is available will help your decision-making process.

Making a confident decision about your breast cancer treatment type involves more than one aspect. The good news is that when detected early, breast cancer treatment is often successful.

You should become familiar with the types of treatment available, the success rates, potential side effects, and why the treatment being recommended is best for your situation.

Breast Cancer Treatment Types

Take the time you need to sort out your treatment options. Your physician may suggest a variety of treatment options and may also suggest that you consider taking part in a breast cancer treatment trial.

While learning and evaluating all of this information can take some time, its better to take the time necessary. Sometimes you may even want to get a second opinion from another medical professional.

There are various treatment options available for different types and stages of breast cancer. These treatment types are based on four main techniques: surgery, quimiotherapy, radiotherapy and hormonal treatment. The primary breast cancer treatment is determined by tumor factors and by patient preference.

Obviously the goal of treatment is to completely remove the cancer and prevent it from coming back. This may involve more than one type of treatment. The mainstay of breast cancer treatment is surgery, with possible chemotherapy and/or radiotherapy.

The aesthetic outcome of breast cancer treatment is an important factor in breast cancer. The visualization work for your breast cancer treatment should be tailored to you needs and the way you perceive the outcome.

Dealing with the physical aspects of breast cancer treatment is only one part of the healing processbut it is an important process that you should consider just as intently as the other portions of your treatment.

Every woman diagnosed with breast cancer wants complete recovery and the ability to return to a normal life. The path to total recovery may be filled with time consuming treatments and recovery processes.

There is no easy solution, but there are millions of breast cancer survivors who have returned to happy normal lives.

The rate of people affected by breast cancer in the United States fell 7 percent in 2003, a year after millions of women halted hormone replacement therapy, a study has revealed.

The decline was even more noticeable in older women who are more sensitive to estrogen, according to the analysis of National Cancer Institute data presented yesterday at a symposium in San Antonio. The decline in women between 50 and 69 years of age fell a remarkable 12 percent.

The research, conducted at the M.D. Anderson Cancer Center in Houston, discovered that 14,000 fewer women were diagnosed with breast cancer in 2003 than in 2002, when an estimated 203,500 cases were reported. Researchers link the decline in cases to the mass halt on hormone replacement therapy after a study proved that the added estrogen increased the risk of developing breast cancer.

“Something went right in 2003, and it seems that it was the decrease in the use of hormone therapy,” said Peter Ravdin, a professor at M.D. Anderson and the study’s co-author. He went on to caution that researchers are not able to prove a direct cause- and-effect relationship at this time.

In 2002, the Women’s Health Initiative study involving 16,608 women using hormone replacement therapy was ended abruptly after higher rates of breast cancer were noted. Breast cancer is the most common form of cancer among American women.

In September, a study was published claiming the drop in breast cancer in 2003 was linked directly to the decline in the use of Premarin, an estrogen replacement product made by Wyeth and once the most prescribed U.S. pharmaceutical product.

“Breast cancer is a complex disease and the causes are not known,” said Candace Steele on behalf of Wyeth, in an e- mailed statement. “It is simply inappropriate to make any speculative statements based on the M.D. Anderson Cancer Center analysis. Even the researchers state they cannot give the definitive cause. Clearly more studies are warranted.”

The rate of breast cancer diagnoses increased steadily at 1.7 percent annually from 1990 to 98, before decreasing slightly, 1 percent a year from 1998 to 2002, the study determined. By the end of 2003, the rate had dropped 7 percent when age adjustments were made.

“We’re seeing this turnaround in breast cancer diagnoses; the question is why,” commented Brenda Edwards, associate director of the surveillance research program at the National Cancer Institute in Bethesda, Maryland. “There are many factors that could be out there, including screening rates.”

Edwards also noted that Mammography rates are leveling off, which may be suppressing the rates of diagnosis without reducing the actual rate of the disease. For now though, researchers can point to what seems to be a link between the decline of cases and the abandonment of hormone replacement therapy, she added.

“We can’t show cause,” she said. “We’re just saying these two things seem to be occurring at a similar time.”

She continued that it will take years of additional research to determine the real cause, but added that researchers are currently working on 2004 statistics to see if the decline will continue or stabilize. The study was funded solely by the National Cancer Institute and M.D. Anderson.